Green Cross Holdings Corporation (KRX:005250)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,900
+180 (1.42%)
Apr 16, 2025, 3:30 PM KST
-19.22%
Market Cap 577.51B
Revenue (ttm) 2.20T
Net Income (ttm) 23.78B
Shares Out 45.40M
EPS (ttm) 523.69
PE Ratio 24.29
Forward PE n/a
Dividend 500.00 (3.93%)
Ex-Dividend Date Dec 27, 2024
Volume 49,628
Average Volume 59,798
Open 12,720
Previous Close 12,720
Day's Range 12,670 - 12,980
52-Week Range 12,000 - 18,490
Beta 1.10
RSI 39.16
Earnings Date Mar 20, 2025

About Green Cross Holdings

Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1967
Employees 151
Stock Exchange Korea Stock Exchange
Ticker Symbol 005250
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.